NCT06757257View on ClinicalTrials.gov

Special Drug Use-results Survey for Long-term Use (Fostamatinib)

RecruitingOBSERVATIONAL
Enrollment

149

Participants

Timeline

Start Date

May 29, 2023

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2028

Conditions
Chronic Idiopathic Thrombocytopenic Purpura
Interventions
DRUG

fostamatinib

oral administration

Trial Locations (1)

Unknown

RECRUITING

Research site, Tokyo and Japanese Other Cities

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY